Abstract WP171: Are We Correctly Measuring Cerebrovascular Reserve Capacity: A Study on Multiple Sequential Post-Acetazolamide Injection Cerebral Blood Flow Measurements Using Arterial Spin Labeling in a Moyamoya Patient Population?

Abstract

Introduction: Cerebrovascular reserve capacity (CVRC), an important predictor and prognostic factor for patients with moyamoya disease (MMD), can be derived by measuring cerebral blood flow (CBF) before and after administration of acetazolamide (ACZ). Commonly, a single CBF measurement is performed after ACZ injection at a time point varying between 5 to 20 minutes, whereas the dynamic temporal response using sequential CBF measurements has not been studied extensively. Furthermore, current literature reports group averaged CVRCs with high standard deviations indicating a patient-specific CVRC is spread over a wide range of values. The aim of this study was to assess the temporal dynamic response of CBF and derived CVRC during the ACZ challenge using arterial spin labeling in patients with MMD. Methods: Ten patients with MMD were included before and/or after revascularisation surgery and examined on a 3T MR scanner. CBF maps, based on 3D-pseudocontineous arterial spin labeling, were acquired before and 5, 15 and 25 minutes after an i.v. ACZ injection and registered to each patient’s 3D-T1-weighted image. A vascular territory template was spatially normalised to patient-specific space, defined by the 3D-T1-weighted image, including bilateral ACA, MCA and PCA. A post label delay of 2500 ms and large regions-of-interests were used to account for possible arterial transit time artefacts. CVRC was calculated as CBF augmentation post-ACZ injection relative to baseline. Results: A total of sixteen examinations were analysed. Average peak CBF augmentation occurred at 5 min post-ACZ injection, successively decreasing at 15 - and 25 min post-ACZ injection . CVRC followed a similar pattern. Peak CBF augmentation mostly occurred at 5 min for all vascular regions (frequency distribution 5 min: 64 %, 15 min: 23 %, 25 min: 13 %). Average ratio between CVRC calculated using 15 min CBF augmentation and CVRC using true peak CBF augmentation (5, 15 or 25 min) was 0.80 to 0.90 for all vascular regions. Conclusion: CVRC assessed using 15 min as a single post-ACZ injections time point may underestimate CVRC in average by 10 % to 20 % because of individual temporal patient response. The use of multiple post-injection time points is warranted.